Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases

British Journal of Surgery

Volumn 96, Issue 1, 2009, Pages 95-103

  Mentha, G ^a   Terraz, S ^a   Morel, P ^a   Andres, A ^a   Giostra, E ^a   Roth, A ^a   Rubbia Brandt, L ^a   Majno, P ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEASIBILITY STUDIES; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PORTAL VEIN; POSTOPERATIVE CARE; REOPERATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 58149520247     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.6436     Document Type: Article

References (28)

1. Zorzi D, Mullen JT, Abdalla EK, Pawlik TM, Andres A, Muratore A et al. Comparison between hepatic wedge resection and anatomic resection metastases. J Gastrointest Surg 2006; 10: 86-94.
2. Andres A, Majno P, Morel P, Rubbia-Brandt L, Giostra E, Gervaz P et al. Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score. Ann Surg Oncol 2008; 15: 134-143.
3. Adam R. Colorectal cancer with synchronous liver metastases. Br J Surg 2007; 94: 129-131.
4. Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 2000; 232: 777-785.
5. Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg 2004; 240: 1037-1051.
6. Kim KW, Kim AY, Kim TK, Park SH, Kim HJ, Lee YK et al. Small (
7. Mentha G, Majno P, Terraz S, Rubbia-Brandt L, Gervaz P, Andres A et al. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour. Eur J Surg Oncol 2007; 33(Suppl 2): S76-S83.
8. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318.
9. Parks R, Gonen M, Kemeny N, Jarnagin W, D'Angelica M, DeMatteo R et al. Adjuvant chemotherapy improves survival after resection of hepatic colorectal metastases: analysis of data from two continents. J Am Coll Surg 2007; 204: 753-763.
10. Rubbia-Brandt L, Audard V, Sartoretti P, Roth AD, Brezault C, Le Charpentier M et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 2004; 15: 460-466.
11. Nakano H, Oussoultzoglou E, Rosso E, Casnedi S, Chenard-Neu MP, Dufour P et al. Sinusoidal injury increases morbidity after major hepatectomy in patients with colorectal liver metastases receiving preoperative chemotherapy. Ann Surg 2008; 247: 118-124.
12. Mentha G, Majno P, Andres A, Rubbia-Brandt L, Morel P, Roth AD. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary. Br J Surg 2006; 93: 872-878.
13. Seium Y, Stupp R, Ruhstaller T, Gervaz P, Mentha G, Philippe M et al. Oxaliplatine combined with irinotecan and 5-fluorouracil/leucovorin (OCFL) in metastatic colorectal cancer: a phase I-II study. Ann Oncol 2005; 16: 762-766.
14. Weber JC, Bachellier P, Oussoultzoglou E, Jaeck D. Simultaneous resection of colorectal primary tumour and synchronous liver metastases. Br J Surg 2003; 90: 956-962.
15. Chua HK, Sondenaa K, Tsiotos GG, Larson DR, Wolff BG, Nagorney DM. Concurrent vs. staged colectomy and hepatectomy for primary colorectal cancer with synchronous hepatic metastases. Dis Colon Rectum 2004; 47: 1310-1316.
16. Bismuth H. Surgical anatomy and anatomical surgery of the liver. World J Surg 1982; 6: 3-9.
17. Pawlik TM, Scoggins CR, Zorzi D, Abdalla EK, Andres A, Eng C et al. Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases. Ann Surg 2005; 241: 715-722.
18. Belghiti J, Noun R, Malafosse R, Jagot P, Sauvanet A, Pierangeli F et al. Continuous versus intermittent portal triad clamping for liver resection: a controlled study. Ann Surg 1999; 229: 369-375.
19. Berney T, Mentha G, Morel P. Total vascular exclusion of the liver for the resection of lesions in contact with the vena cava or the hepatic veins. Br J Surg 1998; 85: 485-488.
20. Rubbia-Brandt L, Giostra E, Brezault C, Roth AD, Andres A, Audard V et al. Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by liver surgery. Ann Oncol 2007; 18: 299-304.
21. Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery 1992; 111: 518-526.
22. Adam R, Aloia T, Lèvi F, Wicherts DA, de Haas RJ, Paule B et al. Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. J Clin Oncol 2007; 25: 4593-4602.
23. Chun YS, Vauthey JN, Ribero D, Donadon M, Mullen JT, Eng C et al. Systemic chemotherapy and two-stage hepatectomy for extensive bilateral colorectal liver metastases: perioperative safety and survival. J Gastrointest Surg 2007; 11: 1498-1505.
24. Falcone A, Masi G, Allegrini G, Danesi R, Pfanner E, Brunetti IM et al. Biweekly chemotherapy with oxaliplatin, irinotecan, infusional fluorouracil, and leucovorin: a pilot study in patients with metastatic colorectal cancer. J Clin Oncol 2002; 20: 4006-4014.
25. Sheikh HY, Valle JW, Palmer K, Sjursen A, Craven O, Wilson G et al. Concurrent irinotecan, oxaliplatin and UFT in first-line treatment of metastatic colorectal cancer: a phase I study. Br J Cancer 2007; 96: 38-43.
26. Van Cutsem E. Progress with biological agents in metastatic colorectal cancer leads to many challenges. J Clin Oncol 2006; 24: 3325-3327.
27. Elias D, De Baere T, Roche A, Ducreux M, Leclere J, Lasser P. During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 1999; 86: 784-788.
28. Kokudo N, Tada K, Seki M, Ohta H, Azekura K, Ueno M et al. Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 2001; 34: 267-272.